Literature DB >> 23697450

Appearances are deceptive...

Daniel Franzen1, Raphael Butsch, Karla Chaloupka.   

Abstract

A 31-year-old man was referred with sudden onset of a painful periorbital angio-oedema. Assuming a first episode of allergic or acquired angio-oedema, the patient was treated with a plasma-derived C1 esterase inhibitor, tranexamic acid and fresh-frozen plasma, after the initial treatment with corticosteroids and histamine blockers was unsuccessful. As blood cultures grew group A streptococci, the diagnosis of periorbital necrotising fasciitis was made, and treatment was subsequently changed to clindamycin and ceftriaxone. Necrotising fasciitis involving the periorbita is a rare and potentially lethal differential diagnosis of acute angio-oedema, in particular if accompanied by severe pain and/or fever. Knowledge on the appearance of this disorder cannot be overemphasised, as only early recognition and immediate initiation of high-dose penicillin and clindamycin combined with tissue debridement help to decrease the mortality and morbidity.

Entities:  

Mesh:

Year:  2013        PMID: 23697450      PMCID: PMC3669976          DOI: 10.1136/bcr-2013-009315

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Invasive streptococcal infection of the periorbita and forehead.

Authors:  R L Gates; W M Cocke; T C Rushton
Journal:  Ann Plast Surg       Date:  2001-11       Impact factor: 1.539

Review 2.  Periorbital necrotizing fasciitis -- a review.

Authors:  Shantha Amrith; Vijaya Hosdurga Pai; Wong Wan Ling
Journal:  Acta Ophthalmol       Date:  2012-04-20       Impact factor: 3.761

Review 3.  Periorbital necrotising fasciitis.

Authors:  Davide Lazzeri; Stefano Lazzeri; Michele Figus; Carlo Tascini; Guido Bocci; Livio Colizzi; Giordano Giannotti; Fulvio Lorenzetti; Daniele Gandini; Romano Danesi; Francesco Menichetti; Mario Del Tacca; Marco Nardi; Marcello Pantaloni
Journal:  Br J Ophthalmol       Date:  2009-11-05       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.